Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

Basit Öğe Kaydı
dc.authorid0000-0002-4563-7027en_US
dc.contributor.authorMesut Akarsu
dc.contributor.authorSoner Onem
dc.contributor.authorIlker Turan
dc.contributor.authorGupse Adali
dc.contributor.authorMeral Akdogan
dc.contributor.authorMurat Akyildiz
dc.contributor.authorMurat Aladag
dc.contributor.authorYasemin Balaban
dc.contributor.authorNilay Danis
dc.contributor.authorMurat Dayangac
dc.contributor.authorGenco Gencdal
dc.contributor.authorHale Gokcan
dc.contributor.authorElif Sertesen
dc.contributor.authorMerve Gurakar
dc.contributor.authorMurat Harputluoglu
dc.contributor.authorGokhan Kabacam
dc.contributor.authorSedat Karademir
dc.contributor.authorMurat Kiyici
dc.contributor.authorRamazan Idilman
dc.contributor.authorZeki Karasu
dc.date.accessioned2022-12-19T12:42:11Z
dc.date.available2022-12-19T12:42:11Z
dc.date.issued2021en_US
dc.departmentMTÖ Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractThe combination of hepatitis B immunoglobulin and potent nucleos(t)ide analogs after liver transplantation is considered as the standard of care for prophylaxis against hepatitis B virus recurrence. However, the recommended doses, route of administration, and duration of HBIG administration remain unclear. Moreover, hepatitis B immunoglobulin-free prophylaxis with potent nucleos(t)ide analogs has shown promising disease outcomes in preventing hepatitis B virus recurrence. The current recommendations, produced by the Turkish Association for the Study of the Liver, Acute Liver Failure and Liver Transplantation Special Interest Group, suggest a reduced need for hepatitis B immunoglobulin administration with effective long-term suppression of hepatitis B virus replication using potent nucleos(t) ide analogs after liver transplantation.en_US
dc.identifier.doi10.5152/tjg.2021.21608
dc.identifier.endpage719en_US
dc.identifier.issue9en_US
dc.identifier.pmid34609299
dc.identifier.scopus2-s2.0-85117952374en_US
dc.identifier.startpage712en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12899/1203
dc.identifier.volume32en_US
dc.identifier.wosWOS:000703346600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAladag, Murat
dc.language.isoenen_US
dc.publisherMurat Aladagen_US
dc.relation.ispartofThe Turkish Society of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectliver transplantationen_US
dc.subjectrecurrenceen_US
dc.titleRecommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantationen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
712-719.pdf
Boyut:
1.07 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu